Medtech, Biotech, and E-Health Startup Valuation

This chapter explores the diverse valuation techniques crafted to meet the specific demands of startups within the realms of MedTech, BioTech, and e-health. It illuminates the unique challenges and prospects that emerge in the context of the swiftly evolving and complex digital health landscape. Conventional valuation methods, such as Discounted Cash Flows (DCF) and market comparables, necessitate a careful adaptation process for their application to startups and scaleups. The chapter underscores the critical need for embracing agile and forward-thinking valuation strategies that can effectively encapsulate and mirror the interdisciplinary nature of this rapidly growing and multifaceted domain, marked by relentless innovation and transformation.